Cannabinoid Biosynthesis Pathway

Cannabinoid biosynthesis refers to the enzymatic pathways through which cannabis plants produce cannabinoids like THC and CBD from precursor molecules. The primary pathway begins with geranyl pyrophosphate and olivetolic acid, which combine via the enzyme CBAS (cannabichromenic acid synthase) or CBDAS (cannabidiolic acid synthase) to form cannabigerolic acid (CBGA)—the mother cannabinoid. From CBGA, decarboxylation and enzyme action produce major cannabinoids including THCA, CBDA, and CBCA. Understanding these pathways is essential for breeders seeking to develop strains with specific cannabinoid profiles, as the expression of synthase enzymes directly determines whether a plant produces primarily THC or CBD-dominant chemotypes.

Breeders leverage knowledge of cannabinoid biosynthesis to select and stabilize desired chemotypes. By identifying and working with the genetic loci controlling CBAS and CBDAS enzyme expression, cultivators can predictably develop high-THC, high-CBD, or balanced hybrid lines for research and commercial breeding programs.